Feb 11,2021

Diabetes treatment start-up funding round takes total capital to £3.6m

UK-based digital health start-up Quin has just closed its latest fundraising round, placing its total capital raised to date at £3.6 million. The Quin app provides personalised diabetes treatment information for people who take insulin to manage their blood glucose levels.

FUNDING SEED
View Analyst & Ambassador Comments
Go to original news
Feb 25,2021

January AI raises $8.8 million for AI that helps people manage their diabetes

January AI, a startup developing a platform that predicts diabetic patients’ responses to certain foods, today announced that it raised $8.8 million. Notable investors in the round included Salesforce CEO Marc Benioff, YouTube cofounder Steve Chen, and former Yahoo! CEO Marissa Mayer.

FUNDING VENTURE ROUND
View Analyst & Ambassador Comments
Go to original news
Mar 16,2021

Glooko Raises $30 Million Financing Round

Glooko Inc., a leading provider of remote patient monitoring and chronic care management solutions including diabetes and obesity has raised a $30 million Series D round of funding. The financing was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic. Proceeds will be used to accelerate organic growth and strategic initiatives across the company’s broad and growing product line of advanced digital health solutions.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Apr 13,2021

CeQur Raises $115 Million Series C5 Financing to Support Commercialization and Scale-Up of Automated Manufacturing for CeQur Simplicity Wearable Insulin-Delivery Device

CeQur, a medical device company committed to simplifying the lives of people with diabetes by revolutionizing insulin-delivery solutions, today announced the close of an oversubscribed $115 million equity financing. The company will use the funds to advance commercial plans for CeQur Simplicity™, including market development activities, a phased commercial launch strategy that includes a limited market release in 2021, and the scale-up of high-volume manufacturing. CeQur Simplicity is both FDA cleared and CE-marked.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Apr 26,2021

Glytec Raises $21 Million To Set the Standard for Hospital Insulin Dosing and Glycemic Management

Glytec today announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. The funding will fuel Glytec’s mission of revolutionizing the role glycemic management plays in the hospital across every department. The combined $9 million debt financing from SVB and $12 million equity investment led by Savitr positions the company to continue its rapid growth by investing in research and development around patient safety, provider workflows and analytics, adding additional talent to its workforce and enhancing integrations with EHRs, mobile apps and other diabetes technology across the continuum of care.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
May 25,2021

Weight loss app Noom scores $540M in Series F funding

Health management and weight loss app Noom landed a whopping $540 million in Series F funding. Silver Lake led the round with participation from Oak HC/FT, Temasek, Novo Holdings, Sequoia Capital, RRE and Samsung Ventures. The company is looking to use the new funds to expand its focus area beyond weight loss. It said the new funds will help it address more conditions, including stress, anxiety, diabetes, hypertension and sleep.

FUNDING SERIES F
View Analyst & Ambassador Comments
Go to original news
Jul 07,2021

BeatO raises USD 5.7 million in funding led by W Health Ventures

BeatO – India's leading digital care ecosystem for chronic condition management – has raised USD 5.7 million in funding led by US-based venture capital firm, W Health Ventures. The funding also saw participation from e-pharmacy Unicorn PharmEasy (a Threpsi Solutions Pvt Ltd brand), Merisis VP and existing investors Orios VP, Leo Capital, and others. With this new funding, BeatO has raised more than USD 10 million over the last year across its Series A and Pre-series B rounds.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 21,2021

Carbon Health banks another $350M to become 'largest primary care provider in the U.S.'

Carbon Health, a primary care provider combining brick-and-mortar clinics with virtual services, is targeting nationwide expansion with the announcement of a hefty $350 million funding round. Led by Blackstone’s Horizon platform, the new investment will help the startup capitalize on its pandemic growth and add new technologic capabilities to its existing digital offerings. It also brings the six-year-old provider to a reported valuation of $3.3 billion.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Aug 25,2021

Better Therapeutics Secures $50 Million Debt Facility From Hercules Capital

Better Therapeutics, Inc today announced it has secured a loan facility for up to $50 million from Hercules Capital, Inc. Funds to support advancement of clinical pipeline and commercialization of first prescription digital therapeutic (PDT) for treating type 2 diabetes

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Aug 31,2021

Oviva grabs $80M for app-delivered healthy eating programs

U.K. startup Oviva, which sells a digital support offering, including for Type 2 diabetes treatment, dispensing personalized diet and lifestyle advice via apps to allow more people to be able to access support, has closed $80 million in Series C funding — bringing its total raised to date to $115 million. The raise, which Oviva says will be used to scale up after a “fantastic year” of growth for the health tech business, is co-led by Sofina and Temasek, alongside existing investors AlbionVC, Earlybird, Eight Roads Ventures, F-Prime Capital, MTIP, plus several angels.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news